Bioresorbable Vascular Scaffolds Versus Stents in Patients With Chronic Total Occlusion

NCT02739685 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

17

Enrollment

OTHER

Sponsor class

Stopped Slow enrollment, access to devices

Conditions

Coronary Artery Disease

Interventions

DEVICE: Everolimus-eluting bioresorbable vascular scaffold
DEVICE: Everolimus-eluting stent

Sponsor

University of Luebeck